BPI21-004: A Qualitative Study Describing Oncology Practitioners’ Approaches to First-Line (1L) Treatment of Metastatic Urothelial Cancer (mUC) in the United States

Authors:
Petros Grivas University of Washington; Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA

Search for other papers by Petros Grivas in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Meaghan Roach PRECISIONheor, New York, NY

Search for other papers by Meaghan Roach in
Current site
Google Scholar
PubMed
Close
 MPH
,
Vivek Pawar EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts; an affiliate of Merck KGaA, Darmstadt, Germany

Search for other papers by Vivek Pawar in
Current site
Google Scholar
PubMed
Close
 PhD
,
Caroline Huber PRECISIONheor, New York, NY

Search for other papers by Caroline Huber in
Current site
Google Scholar
PubMed
Close
 MPH
,
Suepattra May-Slatter PRECISIONheor, New York, NY

Search for other papers by Suepattra May-Slatter in
Current site
Google Scholar
PubMed
Close
 MPH, PhD
,
Isha Desai PRECISIONheor, New York, NY

Search for other papers by Isha Desai in
Current site
Google Scholar
PubMed
Close
 MPH
,
Jane Chang Pfizer Inc, New York, NY

Search for other papers by Jane Chang in
Current site
Google Scholar
PubMed
Close
 MPH
, and
Murtuza Bharmal EMD Serono, Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany

Search for other papers by Murtuza Bharmal in
Current site
Google Scholar
PubMed
Close
 PhD
Restricted access

Corresponding Author: Murtuza Bharmal, PhD
  • Collapse
  • Expand

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1577 674 171
PDF Downloads 395 0 0
EPUB Downloads 0 0 0